Infectious Disease

Alice McHardy of the Helmholtz Centre for Infection Research in Germany will use a computational approach to engineer a more stable, neuraminidase (NA)-like antigen for use in influenza vaccines to increase both the duration and the breadth of protection against multiple influenza strains. Seasonal influenza viruses are constantly mutating, and current vaccines designed to target the variable, but strongly immunogenic, surface antigen, hemagglutinin (HA), must be frequently replaced.

Dr. Yoshihiro Kawaoka of the University of Tokyo in Japan will develop broadly effective influenza vaccines by mixing together epitopes of conserved fragments of the viral hemagglutinin (HA) protein, which only elicit a weak immune response, together with millions of different, non-naturally occurring fragments that elicit a strong immune response, to induce broadly cross-reacting antibodies. Influenza is of world-wide concern severely impacting public health and the global economy. Tens of millions of reported cases result in tens of thousands of deaths annually in the U.S.

James Berkley and Abdi Abdirahman of the University of Oxford in the United Kingdom will test whether metagenomic analysis of clinical samples from patients with suspected infectious diseases can better identify the causative pathogens than current diagnostic methods, to help improve treatment. In Africa and Asia, many severely malnourished infants die after being discharged from a hospital likely due to infectious disease syndromes such as pneumonia, diarrhea, and sepsis.

Erika Linnander of Yale University in the U.S. will use the social influence of rotating savings and credit associations (ROSCAs) – groups who save and borrow together– to increase demand for routine immunizations in Cameroon and Ethiopia. Both these countries have lower than average vaccination coverage and high levels of ROSCA participation. ROSCAs, associations whose members contribute to a fund that can be paid out in whole or in part to each member in rotation, are a savings vehicle for those who may not have access to formal financial institutions.

Federico Costa of the Federal University of Bahia, Brazil, Mitermayer Galvão dos Reis of Fiocruz, Brazil, and Nathan Grubaugh and Albert I Ko of Yale University in the U.S. will establish metagenomic next generation sequencing in clinical settings in an urban region of Brazil classified as an infectious disease ‘hot spot’ to help develop new diagnostics and identify emerging pathogens.

Shola Dele-Olowu of the Clinton Health Access Initiative in Nigeria will consult with a team of community members and health professionals to improve the efficiency of routine immunizations in primary health centers in Nigeria. The vaccination rate in Nigeria varies: while the overall average is 33%, in some areas only 3% of the population is vaccinated. Historical issues with service delivery including long wait times and lack of information have caused fear and mistrust of the healthcare system among caregivers.

Jignesh Patel of the Indian Institute of Technology Hyderabad in India will increase vaccination coverage among low-income urban populations in India by designing a mobile vaccine service including a smartphone-based management application that provides customized vaccinations at homes and schools and at lower cost. Vaccination offers excellent protection against many diseases, however coverage is low among low-income populations in urban centers: immunization at private clinics is unaffordable, and public clinics have longer wait times leading to lost wages.

Rumi Chunara of New York University in the U.S. will collect data from mobile phones of healthcare workers to develop algorithms that will help prioritize healthcare resources to increase vaccine coverage in Punjab, Pakistan. Immunization is one of the most cost-effective and successful public health strategies and is estimated to prevent up to three million deaths each year. Still, many rural areas of low- and middle-income countries have an under-vaccinated population due to a lack of formal education and awareness of the importance of vaccinations.

Paul Namwanja of the Community Health Centre, Busabala in Uganda will implement mobile technology for village health teams to monitor households and childhood vaccinations on remote islands in Uganda and to establish public-private partnerships with community health workers and boat owners to improve vaccine coverage. Vaccination rates on Ugandan islands are significantly lower than the national level because of unreliable transportation to access mainland healthcare centers; island residents rely on commercial fishing boats to travel and face long wait times for healthcare service.

Subhash Chandir, Danya Arif, and Ali Habib of IRD Global in Singapore will develop a text-based immunization chatbot that uses artificial intelligence (AI) and natural language processing to provide vaccine education and practical information to caregivers to improve vaccine coverage in Pakistan. Although free clinics exist, many children remain incompletely vaccinated because caregivers are unaware of the importance of immunization and uninformed about clinic locations and schedules.